Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX - Get Report) stock, but tentative about paying the going market price of $5.21/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $3 strike, which has a bid at the time of this writing of 32 cents. Collecting that bid as the premium represents a 10.7% return against the $3 commitment, or a 8.4% annualized rate of return (at Stock Options Channel we call this the YieldBoost).Selling a put does not give an investor access to BCRX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $3 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless BioCryst Pharmaceuticals, Inc. sees its shares fall 41.8% and the contract is exercised (resulting in a cost basis of $2.68 per share before broker commissions, subtracting the 32 cents from $3), the only upside to the put seller is from collecting that premium for the 8.4% annualized rate of return. Below is a chart showing the trailing twelve month trading history for BioCryst Pharmaceuticals, Inc., and highlighting in green where the $3 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the January 2019 put at the $3 strike for the 8.4% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for BioCryst Pharmaceuticals, Inc. (considering the last 253 trading day closing values as well as today's price of $5.21) to be 73%. For other put options contract ideas at the various different available expirations, visit the BCRX Stock Options page of StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Ford Invests $500 Million in Sustainable Energy Car Company Rivian
The two companies are forming a strategic partnership that will see Ford build a new electric vehicle using a Rivian platform.
Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
Biogen Shares Fall After Drugmaker Meets Earnings Estimates
The stock dips after the drugmaker beats quarterly revenue estimates and earnings meet forecasts.
Caterpillar Rises as Profit Tops Estimates on Strong Machinery Sales
Caterpillar profit beat analysts' forecasts on strong machinery and equipment sales, a sign that tariffs and an economic slowdown aren't having as strong an impact as perceived.
Occidental Petroleum Trumps Chevron With $57 Billion Takeover Bid for Anadarko
Occidental Petroleum makes a formal proposal to buy Anadarko Petroleum in a deal that would value the oil services group at $57 billion and trumps a pending proposal from Chevron.